JMP Securities Maintains Jasper Therapeutics(JSPR.US) With Buy Rating, Maintains Target Price $70

Moomoo News03:32 ET · Ratings

Jasper Therapeutics Positioned for Success in Urticaria Market With Upcoming Briquilimab Data

TipRanks00:45 ET

3 Best Stocks to Buy Now, 1/3/2025, According to Top Analysts

TipRanksJan 3 01:52 ET · Ratings

Analysts Are Bullish on These Healthcare Stocks: Jasper Therapeutics (JSPR), Celldex (CLDX)

TipRanksJan 2 07:40 ET · Ratings

Jasper Launches AI Studio, Empowering Enterprise Marketing Teams to Build & Scale Generative AI Solutions

PR NewswireDec 16, 2024 09:00 ET

Insider Sale: Chief Operating Officer of $JSPR (JSPR) Sells 900 Shares

Quiver QuantitativeDec 12, 2024 20:16 ET